Skip to main content

Peer Review reports

From: Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer

Original Submission
14 Jun 2017 Submitted Original manuscript
14 Sep 2017 Reviewed Reviewer Report - Tanya Dorff
28 Sep 2017 Reviewed Reviewer Report - Simon Crabb
4 Dec 2017 Author responded Author comments - Marina Pulido
Resubmission - Version 2
4 Dec 2017 Submitted Manuscript version 2
5 Dec 2017 Reviewed Reviewer Report - Simon Crabb
22 Dec 2017 Author responded Author comments - Marina Pulido
Resubmission - Version 3
22 Dec 2017 Submitted Manuscript version 3
23 Jan 2018 Author responded Author comments - Marina Pulido
Resubmission - Version 4
23 Jan 2018 Submitted Manuscript version 4
Publishing
29 Jan 2018 Editorially accepted
17 Feb 2018 Article published 10.1186/s12885-018-4059-5

You can find further information about peer review here.

Back to article page